المؤلفون: JG Berdeja, AY Krishnan, A Oriol, NWV Donk, P Rodríguez-Otero, E Askari, M Mateos, MC Minnema, LJ Costa, R Verona, BW Hilderq, S Girgisq, T Prior, JS Russell, JD Goldberg, A Chari

المصدر: Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S215-S216 (2021)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2531137921005125; https://doaj.org/toc/2531-1379

URL الوصول: https://doaj.org/article/d752b36965e449ab9c5a34f0a12d8535

المؤلفون: Tanenbaum HC; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Scientific Research & Development, Embark Veterinary, Ithaca, New York, USA., Birmann BM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Bertrand KA; Slone Epidemiology Center, Boston University, Boston, Massachusetts, USA., Teras LR; Intramural Research Department, American Cancer Society, Atlanta, Georgia, USA., Krishnan AY; City of Hope Medical Center, California, USA., Pourhassan H; City of Hope Medical Center, California, USA., Goldsmith S; City of Hope Medical Center, California, USA., Cannavale K; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Wang SS; City of Hope Medical Center, California, USA., Chao CR; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.

المصدر: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2023 Mar; Vol. 6 (3), pp. e1755. Date of Electronic Publication: 2022 Dec 04.

نوع المنشور: Review; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

مواضيع طبية MeSH: Monoclonal Gammopathy of Undetermined Significance*/diagnosis , Monoclonal Gammopathy of Undetermined Significance*/epidemiology , Multiple Myeloma*/diagnosis , Multiple Myeloma*/epidemiology, Humans ; Electronic Health Records ; Risk Factors ; Predictive Value of Tests

المؤلفون: Costa LJ; University of Alabama at Birmingham, Birmingham, AL, USA. ljcosta@uabmc.edu., Iacobelli S; Rome University Tor Vergata, Rome, Italy., Pasquini MC; CIBMTR and Medical College of Wisconsin, Milwaukee, WI, USA., Modi R; University of Alabama at Birmingham, Birmingham, AL, USA., Giaccone L; University of Torino, Torino, Italy., Blade J; University of Barcelona, Barcelona, Spain., Schonland S; University Hospital Heidelberg, Heidelberg, Germany., Evangelista A; Citt Della Salute E Della Scienza, Torino, Italy., Perez-Simon JA; Universidad de Sevilla, Sevilla, Spain., Hari P; CIBMTR and Medical College of Wisconsin, Milwaukee, WI, USA., Brown EE; University of Alabama at Birmingham, Birmingham, AL, USA., Giralt SA; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Patriarca F; University of Udine, Udine, Italy., Stadtmauer EA; University of Pennsylvania, Philadelphia, PA, USA., Rosinol L; Josep Carreras Research Institute, Barcelona, Spain., Krishnan AY; City of Hope Medical Center, Duarte, CA, USA., Gahrton G; Karolinska University Hospital, Stockholm, Sweden., Bruno B; University of Torino, Torino, Italy.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2020 Sep; Vol. 55 (9), pp. 1810-1816. Date of Electronic Publication: 2020 Apr 14.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease* , Hematopoietic Stem Cell Transplantation*, Disease-Free Survival ; Humans ; Neoplasm Recurrence, Local ; Transplantation Conditioning ; Transplantation, Autologous ; Transplantation, Homologous

المؤلفون: Stewart AK; Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA. Stewart.Keith@mayo.edu., Krishnan AY; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Medical Center, Duarte, CA, USA., Singhal S; Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Boccia RV; Center for Cancer and Blood Disorders, Bethesda, MD, USA., Patel MR; Florida Cancer Specialists, Sarasota, FL, USA.; Sarah Cannon Research Institute, Nashville, TN, USA., Niesvizky R; Multiple Myeloma Center, New York Presbyterian Hospital-Cornell Medical Center, New York, NY, USA., Chanan-Khan AA; Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL, USA., Ailawadhi S; Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL, USA., Brumm J; Genentech, Inc., South San Francisco, CA, USA., Mundt KE; Genentech, Inc., South San Francisco, CA, USA., Hong K; Genentech, Inc., South San Francisco, CA, USA., McBride J; Genentech, Inc., South San Francisco, CA, USA., Shon-Nguyen Q; Genentech, Inc., South San Francisco, CA, USA., Xiao Y; Genentech, Inc., South San Francisco, CA, USA., Ramakrishnan V; Genentech, Inc., South San Francisco, CA, USA., Polson AG; Genentech, Inc., South San Francisco, CA, USA., Samineni D; Genentech, Inc., South San Francisco, CA, USA., Leipold D; Genentech, Inc., South San Francisco, CA, USA., Humke EW; Genentech, Inc., South San Francisco, CA, USA., McClellan JS; Genentech, Inc., South San Francisco, CA, USA., Berdeja JG; Sarah Cannon Research Institute, Nashville, TN, USA.

المصدر: Blood cancer journal [Blood Cancer J] 2019 Feb 04; Vol. 9 (2), pp. 17. Date of Electronic Publication: 2019 Feb 04.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Immunoconjugates/*therapeutic use , Multiple Myeloma/*drug therapy , Multiple Myeloma/*pathology , Receptors, Fc/*antagonists & inhibitors, Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Agents, Immunological/pharmacokinetics ; Biomarkers ; Drug Monitoring ; Drug Resistance, Neoplasm ; Female ; Follow-Up Studies ; Humans ; Immunoconjugates/administration & dosage ; Immunoconjugates/adverse effects ; Immunoconjugates/pharmacokinetics ; Immunophenotyping ; Male ; Middle Aged ; Recurrence ; Retreatment ; Treatment Outcome

المؤلفون: Chari A; Icahn School of Medicine at Mount Sinai, New York, New York., Lonial S; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia., Mark TM; Weill Cornell Medical College, New York, New York., Krishnan AY; Department of Hematology and Hematopoietic Cell Transplantation and Judy and Bernard Briskin Center for Multiple Myeloma, City of Hope National Medical Center, Duarte, California., Stockerl-Goldstein KE; Division of Medical Oncology - Bone Marrow Transplantation and Leukemia Section, Washington University, St. Louis, Missouri., Usmani SZ; Levine Cancer Institute, Charlotte, North Carolina., Londhe A; Janssen Research & Development, LLC, Titusville, New Jersey., Etheredge D; Janssen Research & Development, LLC, Titusville, New Jersey., Fleming S; Janssen Research & Development, LLC, Titusville, New Jersey., Liu B; Janssen Research & Development, LLC, Spring House, Pennsylvania., Ukropec J; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania., Lin TS; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania., Jagannath S; Icahn School of Medicine at Mount Sinai, New York, New York., Nooka AK; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

المصدر: Cancer [Cancer] 2018 Nov 15; Vol. 124 (22), pp. 4342-4349. Date of Electronic Publication: 2018 Nov 05.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*administration & dosage , Antineoplastic Agents, Immunological/*administration & dosage , Multiple Myeloma/*drug therapy , Neoplasm Recurrence, Local/*drug therapy, Acetates/administration & dosage ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Cyclopropanes ; Drug Administration Schedule ; Drug Approval ; Female ; Humans ; Infusions, Intravenous ; Injection Site Reaction/prevention & control ; Male ; Middle Aged ; Quinolines/administration & dosage ; Sulfides ; Survival Analysis ; Treatment Outcome ; United States

المؤلفون: Wang X; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California. xiuwang@coh.org., Walter M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Urak R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Weng L; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Huynh C; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Lim L; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Wong CW; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Chang WC; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Thomas SH; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Sanchez JF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California.; Judy and Bernard Briskin Center for Multiple Myeloma, City of Hope, Duarte, California., Yang L; Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, California., Brown CE; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Pichiorri F; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California.; Judy and Bernard Briskin Center for Multiple Myeloma, City of Hope, Duarte, California., Htut M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California.; Judy and Bernard Briskin Center for Multiple Myeloma, City of Hope, Duarte, California., Krishnan AY; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California.; Judy and Bernard Briskin Center for Multiple Myeloma, City of Hope, Duarte, California., Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Jan 01; Vol. 24 (1), pp. 106-119. Date of Electronic Publication: 2017 Oct 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Lenalidomide/*pharmacology , Multiple Myeloma/*immunology , Multiple Myeloma/*metabolism , Receptors, Antigen, T-Cell/*metabolism , Receptors, Chimeric Antigen/*metabolism , Signaling Lymphocytic Activation Molecule Family/*genetics , T-Lymphocytes/*immunology , T-Lymphocytes/*metabolism, Angiogenesis Inhibitors/pharmacology ; Animals ; Cell Line, Tumor ; Cytotoxicity, Immunologic/drug effects ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Immunologic Factors/pharmacology ; Immunological Synapses/immunology ; Immunotherapy, Adoptive ; Mice ; Multiple Myeloma/pathology ; Multiple Myeloma/therapy ; Receptors, Chimeric Antigen/genetics ; Signaling Lymphocytic Activation Molecule Family/immunology ; T-Cell Antigen Receptor Specificity/drug effects ; T-Lymphocytes/drug effects ; Xenograft Model Antitumor Assays

المؤلفون: Krishnan AY; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, California; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California. Electronic address: akrishnan@coh.org., Palmer J; Department of Information Sciences, City of Hope, Duarte, California., Nademanee AP; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Chen R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Popplewell LL; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Tsai NC; Department of Information Sciences, City of Hope, Duarte, California., Sanchez JF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Simpson J; Clinical Trials Office, City of Hope, Duarte, California., Spielberger R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California; Southern California Kaiser Permanente Bone Marrow Transplant Program, Los Angeles, California., Yamauchi D; Department of Diagnostic Radiology, City of Hope, Duarte, California., Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California.

المصدر: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2017 Jun; Vol. 23 (6), pp. 922-929. Date of Electronic Publication: 2017 Mar 04.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Carden Jennings Publishing Country of Publication: United States NLM ID: 9600628 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6536 (Electronic) Linking ISSN: 10838791 NLM ISO Abbreviation: Biol Blood Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Lymphoma, Non-Hodgkin/*therapy, Adult ; Aged ; Antigens, CD20/analysis ; Carmustine/therapeutic use ; Cytarabine/therapeutic use ; Etoposide/therapeutic use ; Female ; Histological Techniques ; Humans ; Male ; Melphalan/therapeutic use ; Middle Aged ; Remission Induction ; Salvage Therapy/methods ; Survival Analysis ; Young Adult

SCR Protocol: BEAM regimen

المؤلفون: Anderson KC; Dana-Farber/Brigham and Women’s Cancer Center, Alsina M; Moffitt Cancer Center, Atanackovic D; Huntsman Cancer Institute at the University of Utah, Biermann JS; University of Michigan Comprehensive Cancer Center, Chandler JC; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Costello C; UC San Diego Moores Cancer Center, Djulbegovic B; Moffitt Cancer Center, Fung HC; Fox Chase Cancer Center, Gasparetto C; Duke Cancer Institute, Godby K; University of Alabama at Birmingham Comprehensive Cancer Center, Hofmeister C; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Holmberg L; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Holstein S; Roswell Park Cancer Institute, Huff CA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Kassim A; Vanderbilt-Ingram Cancer Center, Krishnan AY; City of Hope Comprehensive Cancer Center, Kumar SK; Mayo Clinic Cancer Center, Liedtke M; Stanford Cancer Institute, Lunning M; Fred & Pamela Buffett Cancer Center, Raje N; Massachusetts General Hospital Cancer Center, Reu FJ; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Singhal S; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Somlo G; City of Hope Comprehensive Cancer Center, Stockerl-Goldstein K; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Treon SP; Dana-Farber/Brigham and Women’s Cancer Center, Weber D; The University of Texas MD Anderson Cancer Center, Yahalom J; Memorial Sloan Kettering Cancer Center, Shead DA; National Comprehensive Cancer Network, Kumar R; National Comprehensive Cancer Network

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2016 Apr; Vol. 14 (4), pp. 389-400.

نوع المنشور: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma/*diagnosis , Multiple Myeloma/*therapy, Humans

المؤلفون: Uy GL; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Costa LJ; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Hari PN; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Zhang MJ; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA., Huang JX; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Anderson KC; Hematologic Oncology Treatment Center, Dana-Farber Cancer Institute, Boston, MA, USA., Bredeson CN; The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Callander NS; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Cornell RF; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Perez MA; Servicio de Oncohematologia, Hospital Infantil Universitario Nino Jesus, Madrid, Spain., Dispenzieri A; Department of Hematology, Mayo Clinic, Rochester, MN, USA., Freytes CO; South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio, TX, USA., Gale RP; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK., Garfall A; Division of Hematology/Oncology, Perelman Center for Advanced Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Gertz MA; Department of Hematology, Mayo Clinic, Rochester, MN, USA., Gibson J; Haematology Department, Royal Prince Alfred Hospital Institute of Haematology, Camperdown, New South Wales, Australia., Hamadani M; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Lazarus HM; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA., Kalaycio ME; Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH, USA., Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Kharfan-Dabaja MA; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Krishnan AY; Department of Hematology/Oncology, City of Hope National Medical Center, Duarte, CA, USA., Kumar SK; Department of Hematology, Mayo Clinic, Rochester, MN, USA., Kyle RA; Department of Hematology, Mayo Clinic, Rochester, MN, USA., Landau HJ; Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lee CH; Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital/SA Pathology, Adelaide, South Australia, Australia., Maiolino A; Hospital Universitário Clementinio Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Marks DI; Pediatric Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, UK., Mark TM; Department of Medicine, New York Presbyterian Hospital at Cornell, New York, NY, USA., Munker R; Section of Hematology/Oncology, Department of Internal Medicine, Louisiana State University Health Shreveport, Shreveport, LA, USA., Nishihori T; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Olsson RF; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden., Ramanathan M; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worcester, MA, USA., Rodriguez TE; Bone Marrow Transplant Program, Loyola University Medical Center, Chicago, IL, USA., Saad AA; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Schiller GJ; Bone Marrow Transplant Program, UCLA Center for Health Sciences, Los Angeles, CA, USA., Schouten HC; Department of Hematology, Academische Ziekenhuis, Maastricht, The Netherlands., Schriber JR; Cancer Transplant Institute, Virginia G. Piper Cancer Center, Scottsdale, AZ, USA.; Arizona Oncology, Scottsdale, AZ, USA., Scott E; Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR, USA., Seo S; Department of Vaccine and Infectious Disease, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Sharma M; Department of Hematology/Oncology, Thomas Jefferson University, Philadelphia, PA, USA., Ganguly S; Blood and Marrow Transplantation, Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, USA., Stadtmauer EA; Division of Hematology/Oncology, Perelman Center for Advanced Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Tay J; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada., To LB; Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital/SA Pathology, Adelaide, South Australia, Australia., Vesole DH; Hackensack University Medical Center, Hackensack, NJ, USA., Vogl DT; Division of Hematology/Oncology, Perelman Center for Advanced Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Wagner JL; Department of Hematology/Oncology, Thomas Jefferson University, Philadelphia, PA, USA., Wirk B; Seattle Cancer Care Alliance, Seattle, WA, USA., Wood WA; Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA., D'Souza A; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2015 Dec; Vol. 50 (12), pp. 1513-8. Date of Electronic Publication: 2015 Aug 24.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Mobilization/*methods , Multiple Myeloma/*blood , Multiple Myeloma/*therapy, Adolescent ; Adult ; Aged ; Autografts ; Disease-Free Survival ; Female ; Humans ; Leukocyte Count ; Male ; Middle Aged ; Platelet Count ; Prospective Studies ; Recovery of Function ; Survival Rate

المؤلفون: Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Singhal S, Smith C, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R

مؤلفون مشاركون: National Comprehensive Cancer Network

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2015 Nov; Vol. 13 (11), pp. 1398-435.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma/*diagnosis , Multiple Myeloma/*therapy, Disease Management ; Humans ; Multiple Myeloma/etiology